Elsevier

Ophthalmology

Volume 104, Issue 3, March 1997, Pages 460-465
Ophthalmology

Rate of Visual Field Loss in Retinitis Pigmentosa

https://doi.org/10.1016/S0161-6420(97)30291-7Get rights and content

Purpose: The authors quantitate the rate of visual field loss in patients with retinitis pigmentosa as it relates to different clinical field phenotypes.

Patients and Methods: Goldmann visual fields were obtained with target V4e in 77 patients and with target II4e in 71 patients who had either isolated or various genetic types of retinitis pigmentosa and who met certain entrance criteria. The visual fields were categorized into five distinct clinical field phenotypes on the basis of their pattern of field loss. Mixed-model methods for the analysis of longitudinal data were used to model the natural logarithm of the visual field area as a function of patient age and clinical field phenotype. The average half-life (time over which half, of the remaining field area would be lost) of the visual field area for each phenotype was computed from the results of this analysis. Visual field data were not analyzed for patients with a normal clinical field phenotype (type 1).

Results: Independent of the field phenotype, average half-life values were 7.3 years for target V4e and 6.8 years for target II4e, which were not statistically different (P = 0.16). Visual fields with partial or complete midperipheral ring scotomas (type 2) and those with only a residual central field (type 4) had a half-life of 9.5 and 9.4 years, respectively, for target V4e, and 8.9 and 8.0 years, respectively, for target II4e. Patients with partial peripheral restriction (type 5) lost visual fields with a half-life of 9.5 years for target V4e and 7.3 years for target II4e. None of these differences in the half-lives between the different phenotypes were statistically significant for either targets V4e or II4e. Fields with a residual central area and remaining temporal and/or-nasal- islands (type 3) had a half-life of 4.8 years for target V4e and 6.0 years for target II4e. The differences in half-lives between type 3 and each of the other field phenotypes were statistically significant for the V4e target, but not for the II4e target.

Conclusions: The results of this study can be useful for counseling patients with retinitis pigmentosa and various visual field phenotypes as to their potential rate of visual field loss.

References (17)

  • EL Berson et al.

    Natural course of retinitis pigmentosa over a three-year interval

    Am J Ophthalmol

    (1985)
  • K Holopigian et al.

    Rates of change differ among measures of visual function in patients with retinitis pigmentosa

    Ophthalmology

    (1996)
  • RW Massof et al.

    A two-stage hypothesis for the natural course of retinitis pigmentosa.

  • RW Massof et al.

    First order dynamics of visual field loss in retinitis pigmentosa

    Clin Vision Sci

    (1990)
  • EL Berson et al.

    A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa

    Arch Ophthalmol

    (1993)
  • JT Pearlman

    Mathematical models of retinitis pigmentosa: a study of the rate of progress in the different genetic forms

    Trans Am Ophthalmol Soc

    (1979)
  • J Gonin

    Le scotome annulaire dans la degenerescence pigmentaire de la retine

    Ann d'Ocul

    (1901)
  • RN Sunga et al.

    Pigmentary degeneration of the retina: early diagnosis and natural history

    Invest Ophthalmol

    (1967)
There are more references available in the full text version of this article.

Cited by (0)

Presented in part at the ARVO Meeting, Ft. Lauderdale, Florida, April 1996.

Supported by a center grant from The Foundation Fighting Blindness, Baltimore, Maryland.

View full text